Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO1998053062) A HUMAN EDG-6 RECEPTOR HOMOLOGUE
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1998/053062 International Application No.: PCT/CA1998/000487
Publication Date: 26.11.1998 International Filing Date: 22.05.1998
Chapter 2 Demand Filed: 18.12.1998
IPC:
A61K 48/00 (2006.01) ,C07K 14/705 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
48
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435
from animals; from humans
705
Receptors; Cell surface antigens; Cell surface determinants
Applicants:
ALLELIX BIOPHARMACEUTICALS, INC. [CA/CA]; 6850 Goreway Drive Mississauga, Ontario L4V 1V7, CA (AllExceptUS)
MUNROE, Donald, G. [CA/CA]; CA (UsOnly)
VYAS, Tejal, B. [CA/CA]; CA (UsOnly)
Inventors:
MUNROE, Donald, G.; CA
VYAS, Tejal, B.; CA
Agent:
CHARI, Santosh, K. ; Orange Chari Pillay Toronto Dominion Bank Tower Toronto-Dominion Centre Suite 3600, P.O. Box 190 Toronto, Ontario M5K 1H6, CA
Priority Data:
08/861,74722.05.1997US
Title (EN) A HUMAN EDG-6 RECEPTOR HOMOLOGUE
(FR) HOMOLOGUE DU RECEPTEUR EDG-6 HUMAIN
Abstract:
(EN) An isolated nucleic acid sequence coding for an amino acid sequence for a novel human EDG-6 receptor homologue is provided. Also provided are purified human EDG-6 receptor polypeptides derived from the nucleic acid and methods and transgenic animals therefor.
(FR) L'invention concerne une séquence d'acide nucléique isolée, qui code une séquence d'acides aminés destinée à un nouvel homologue du récepteur EDG-6 humain. Elle concerne également des polypeptides du récepteur EDG-6 humain purifiés, dérivés dudit acide nucléique, ainsi que des méthodes et des animaux transgéniques pour lesdits dérivés.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, GW, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
CA2290713AU1998074223